In Vitro Therapeutic Efficacy of Furazolidone for Antimicrobial Susceptibility Testing on <i>Campylobacter</i>
<b>Background:</b> <i>Campylobacter</i> causes gastroenteritis worldwide with increasing antimicrobial resistance. Furazolidone (FZD) shows potential in resource-poor areas but needs further study. We aimed to assess the in vitro susceptibility of <i>Campylobacter</i...
Saved in:
| Main Authors: | Jeel Moya-Salazar, Alfonso Terán-Vásquez, Richard Salazar-Hernandez, Víctor Rojas-Zumaran, Eliane A. Goicochea-Palomino, Marcia M. Moya-Salazar, Hans Contreras-Pulache |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Antibiotics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-6382/14/7/636 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Consortium of <i>Lactobacillus crispatus</i> 2029 and <i>Ligilactobacillus salivarius</i> 7247 Strains Shows In Vitro Bactericidal Effect on <i>Campylobacter jejuni</i> and, in Combination with Prebiotic, Protects Against Intestinal Barrier Dysfunction
by: Vyacheslav M. Abramov, et al.
Published: (2024-11-01) -
Antibiotic resistance profiles of Campylobacter species in the South Africa private health care sector
by: Christiana O. Shobo, et al.
Published: (2016-11-01) -
Genome Analysis of the Multidrug-Resistant <i>Campylobacter coli</i> BCT3 of the Sequence Type (ST) 872 Isolated from a Pediatric Diarrhea Case
by: Konstantinos Papadimitriou, et al.
Published: (2025-06-01) -
Antimicrobial resistance in Campylobacter spp. focussing on C. jejuni and C. coli – A narrative review
by: Vathsala Mohan, et al.
Published: (2025-06-01) -
<i>Campylobacter jejuni</i>/<i>coli</i> Infection: Is It Still a Concern?
by: Piero Veronese, et al.
Published: (2024-12-01)